ADJUVANT TRIAL FOR STAGE-II RECEPTOR-POSITIVE BREAST-CANCER - CMF VS CMF+ TAMOXIFEN IN A SINGLE CENTER

被引:20
作者
MAURIAC, L
DURAND, M
CHAUVERGNE, J
BONICHON, F
AVRIL, A
MAGE, P
DILHUYDY, MH
LETREUT, A
WAFFLART, J
MAREE, D
LAGARDE, C
机构
关键词
D O I
10.1007/BF01805842
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:179 / 186
页数:8
相关论文
共 26 条
[1]   10-YEAR EXPERIENCE WITH CMF-BASED ADJUVANT CHEMOTHERAPY IN RESECTABLE BREAST-CANCER [J].
BONADONNA, G ;
VALAGUSSA, P ;
ROSSI, A ;
TANCINI, G ;
BRAMBILLA, C ;
ZAMBETTI, M ;
VERONESI, U .
BREAST CANCER RESEARCH AND TREATMENT, 1985, 5 (02) :95-115
[2]   PROGESTERONE RECEPTORS AS A PROGNOSTIC FACTOR IN STAGE-II BREAST-CANCER [J].
CLARK, GM ;
MCGUIRE, WL ;
HUBAY, CA ;
PEARSON, OH ;
MARSHALL, JS .
NEW ENGLAND JOURNAL OF MEDICINE, 1983, 309 (22) :1343-1347
[3]  
COX DR, 1972, J R STAT SOC B, V34, P187
[4]   ADJUVANT TAMOXIFEN IN POSTMENOPAUSAL BREAST-CANCER - PRELIMINARY-RESULTS OF A RANDOMIZED TRIAL [J].
DELOZIER, T ;
JULIEN, JP ;
JURET, P ;
VEYRET, C ;
COUETTE, JE ;
GRAIC, Y ;
OLLIVIER, JM ;
DERANIERI, E .
BREAST CANCER RESEARCH AND TREATMENT, 1986, 7 (02) :105-110
[5]   ADJUVANT CHEMOTHERAPY WITH AND WITHOUT TAMOXIFEN IN THE TREATMENT OF PRIMARY BREAST-CANCER - 5-YEAR RESULTS FROM THE NATIONAL SURGICAL ADJUVANT BREAST AND BOWEL PROJECT TRIAL [J].
FISHER, B ;
REDMOND, C ;
BROWN, A ;
FISHER, ER ;
WOLMARK, N ;
BOWMAN, D ;
PLOTKIN, D ;
WOLTER, J ;
BORNSTEIN, R ;
LEGAULTPOISSON, S ;
SAFFER, EA .
JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (04) :459-471
[6]  
FISHER B, 1983, BREAST CANCER RES S1, V3, P7
[7]   ANALYSIS OF DOSE INTENSITY FOR ADJUVANT CHEMOTHERAPY TRIALS IN STAGE-II BREAST-CANCER [J].
HRYNIUK, W ;
LEVINE, MN .
JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (08) :1162-1170
[8]  
MAURIAC L, 1983, B CANCER, V70, P160
[9]  
MAURIAC L, 1981, B CANCER, V68, P417
[10]   STRATEGIES TO IDENTIFY OR PREVENT DRUG-RESISTANCE IN CANCER - A PANEL DISCUSSION [J].
MCGUIRE, WL ;
GOLDIE, JH ;
SALMON, SE ;
LING, V .
BREAST CANCER RESEARCH AND TREATMENT, 1985, 5 (03) :257-268